{
  "compound": "THC+CBD (1:1 oral oil)",
  "condition": "TOURETTE_SYNDROME",
  "effect_size": "Moderate (crossover effect)",
  "study_type": "RCT",
  "source": "NORML:TS_RCT_007",
  "participants": "22 adults with severe Tourette syndrome",
  "year": 2023,
  "notes": "Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome",
  "confidence": "medium",
  "abstract": "At week 6 vs baseline: YGTSS total tic score change -8.9 (\u00b17.6) under active vs -2.5 (\u00b18.5) under placebo; mixed-effects model showed greater tic improvement under active treatment (P=0.008)"
}